Stock Earnings

Question 1

What are Citius Oncology Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Citius Oncology Inc has a total asset of $84, Net loss of $-21

Question 2

What are the key financial ratios for CTOR?

Accepted Answer

Citius Oncology Inc's Current ratio is 2.21, has a Net margin is 0, sales per share of $0.

Question 3

How is Citius Oncology Inc's revenue broken down by segment or geography?

Accepted Answer

Currently Citius Oncology Inc data is not available.

Question 4

Is Citius Oncology Inc profitable?

Accepted Answer

no, according to the latest financial statements, Citius Oncology Inc has a net loss of $-21

Question 5

Does Citius Oncology Inc have any liabilities?

Accepted Answer

yes, Citius Oncology Inc has liability of 38

Question 6

How many outstanding shares for Citius Oncology Inc?

Accepted Answer

Citius Oncology Inc has a total outstanding shares of 71.55

Breakdown	TTM	09/30/2024	12/31/2023	09/30/2023	12/31/2022	09/30/2022
Revenue	0	0	--	0	--	0
Revenue Growth (YoY)	--	--	--	--	--	--
Cost of Revenue	--	--	--	--	--	--
Gross Profit	--	--	--	--	--	--
Selling, General & Admin	28	15	--	7	--	1
Research & Development	10	4	--	4	--	3
Operating Expenses	38	20	--	12	--	4
Other Non Operating Income (Expenses)	--	--	--	--	--	--
Pretax Income	-39	-20	--	-12	--	-4
Income Tax Expense	1	0	--	0	--	0
Net Income	-41	-21	--	-12	--	-5
Net Income Growth	--	--	--	--	--	--
Shares Outstanding (Diluted)	71.55	68.05	--	71.3	--	71.3
Shares Change (YoY)	--	--	--	--	--	--
EPS (Diluted)	-0.59	-0.31	--	-0.17	--	-0.07
EPS Growth	--	--	--	--	--	--
Free Cash Flow	0	0	0	0	0	--
Free Cash Flow Per Share	0	0	--	0	--	--
Gross Margin	--	--	--	--	--	--
Operating Margin	0%	0%	--	0%	--	0%
Profit Margin	0%	0%	--	0%	--	0%
Free Cash Flow Margin	0%	0%	--	0%	--	--
EBITDA	--	--	--	--	--	--
EBITDA Margin	--	--	--	--	--	--
D&A For EBITDA	--	--	--	--	--	--
EBIT	-38	-20	--	-12	--	-4
EBIT Margin	0%	0%	--	0%	--	0%
Effective Tax Rate	-2.56%	0%	--	0%	--	0%

Citius Oncology Inc (CTOR) Price